Mekaru Keiko, Yagi Chiaki, Asato Kozue, Masamoto Hitoshi, Sakumoto Kaoru, Aoki Yoichi
Department of Obstetrics and Gynecology, Graduate School of Medical Science University of the Ryukyus 207 Uehara, Nishihara 903-0215 Naha Okinawa Japan.
Reprod Med Biol. 2011 Sep 21;11(2):79-83. doi: 10.1007/s12522-011-0109-2. eCollection 2012 Apr.
We aimed to compare the efficacy of a gonadotropin-releasing hormone (GnRH) antagonist protocol and a GnRH agonist long protocol used in the first in vitro fertilization-embryo transfer (IVF-ET) cycle in an unspecified population of infertile couples.
Fifty and 34 patients were treated with a GnRH agonist long protocol (agonist group) and GnRH antagonist protocol (antagonist group), respectively, in the first treatment cycle. The primary and secondary outcome measures were cumulative live birth rates after fresh and cryopreserved-thawed ETs and incidence of grades II and III ovarian hyperstimulation syndrome (OHSS), respectively.
No significant differences were observed in clinical pregnancy rates (38.0 vs. 32.4%) and live birth rates (22.0 vs. 23.5%), which included both fresh and cryopreserved-thawed ETs, between the 2 groups. However, the incidence of grade III OHSS was significantly lower with the GnRH antagonist protocol than the GnRH agonist long protocol.
Used in the first IVF-ET cycle in an unspecified population of infertile patients, the GnRH antagonist protocol showed the same clinical outcome as the GnRH agonist long protocol.
我们旨在比较促性腺激素释放激素(GnRH)拮抗剂方案与GnRH激动剂长方案在未明确的不育夫妇群体首次体外受精-胚胎移植(IVF-ET)周期中的疗效。
在首个治疗周期中,分别有50例和34例患者接受了GnRH激动剂长方案(激动剂组)和GnRH拮抗剂方案(拮抗剂组)治疗。主要和次要结局指标分别为新鲜及冻融胚胎移植后的累积活产率以及II级和III级卵巢过度刺激综合征(OHSS)的发生率。
两组之间的临床妊娠率(38.0%对32.4%)和活产率(22.0%对23.5%,包括新鲜及冻融胚胎移植)未观察到显著差异。然而,GnRH拮抗剂方案的III级OHSS发生率显著低于GnRH激动剂长方案。
在未明确的不育患者群体的首次IVF-ET周期中使用时,GnRH拮抗剂方案显示出与GnRH激动剂长方案相同的临床结局。